InFocus Capital Partners

About

Portfolio · 1

Galimedix Therapeutics

Novel Treatment for Neurodegenerative Diseases of the Eye and Brain

1 round $2.0M committed Latest: 2019-01

Investment activity

Q&A

What is InFocus Capital Partners' primary investment focus?

InFocus Capital Partners focuses on ophthalmic insights and proven investment, primarily within the Health Tech & Life Sciences sector.

Can you name a notable company in InFocus Capital Partners' portfolio?

A notable company in InFocus Capital Partners' portfolio is Galimedix Therapeutics, which focuses on novel treatments for neurodegenerative diseases of the eye and brain.

What was InFocus Capital Partners' most recent investment activity?

InFocus Capital Partners participated in a Seed round for Galimedix Therapeutics in January 2019, which raised $2M.

What stage of funding does InFocus Capital Partners typically participate in?

According to startupim data, InFocus Capital Partners has participated in Seed stage funding rounds.

What is the typical check size for InFocus Capital Partners?

InFocus Capital Partners' investment range is $2M.

When was InFocus Capital Partners founded?

InFocus Capital Partners was created in May 2024.